In a televised interview on 7 April 2017, the CEO of 23andMe, Anne Wojcicki, discussed the company’s new FDA-approved disease-risk reports and let drop (at about 6:15) that their database now includes more than two million people.
Because of 23andMe’s two-pronged business model (part consumer medical genetics, part genealogy), not all of those individuals will be participating in DNA Relatives, the family matching tool there. Even so, this milestone is great news for genetic genealogy!
I have updated the autosomal testing growth graph, adding this new value to those taken from the edit history of the ISOGG company comparison chart. Feel free to use it in presentations to the genetic genealogy community.